Abbott Laboratories
SWB:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
SWB:ABL
|
US |
|
H
|
Harvey Norman Holdings Ltd
SWB:HNN
|
AU |
|
Barclays PLC
LSE:BARC
|
UK |
|
C
|
Chevron Corp
XHAM:CHV
|
US |
|
B
|
Berkshire Hathaway Inc
DUS:BRH
|
US |
|
H
|
Hermes International SCA
DUS:HMI
|
FR |
|
P
|
PTC Therapeutics Inc
DUS:BH3
|
US |
|
L'Oreal SA
PAR:OR
|
FR |
|
M
|
M&T Bank Corp
DUS:MTZ
|
US |
|
Stora Enso Oyj
F:ENU
|
FI |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 105.54 EUR with a low forecast of 89.7 EUR and a high forecast of 123.13 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
105.54
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 105.54 EUR with a low forecast of 89.7 EUR and a high forecast of 123.13 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 5 years is 16%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
18%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 18%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 17%.
